Table 2.
Cross-sectional at baseline | One-year change in controls | One-year change in exercisers | |||||||
---|---|---|---|---|---|---|---|---|---|
Cholesterol | LCAT | LCAT adj. for cholesterol |
Cholesterol | LCAT | LCAT adj. for cholesterol |
Cholesterol | LCAT | LCAT adj. for cholesterol |
|
LCAT | 0.32** | — | — | 0.51** | — | — | 0.53*** | — | — |
Triglycerides | 0.49**** | 0.28** | 0.15 | 0.30 | 0.31 | 0.19 | 0.20 | 0.38** | 0.33* |
HDL-chol. | −0.06 | 0.02 | 0.04 | 0.11 | −0.10 | −0.19 | 0.01 | 0.06 | 0.06 |
LDL-chol. | 0.93**** | 0.25* | −0.14 | 0.93**** | 0.45** | −0.07 | 0.85**** | 0.31* | −0.31* |
VLDL-chol. | 0.52**** | 0.25* | 0.10 | 0.56*** | 0.42* | 0.19 | 0.43* | 0.42** | 0.25 |
HDL2-mass | −0.16 | −0.16 | −0.12 | −0.20 | −0.13 | −0.03 | −0.15 | 0.01 | 0.11 |
HDL3-mass | 0.24* | 0.29** | 0.23* | 0.16 | −0.14 | −0.26 | 0.35* | 0.23 | 0.06 |
Small LDL- mass |
0.66**** | 0.30** | 0.13 | 0.35 | 0.21 | 0.03 | 0.56*** | 0.40** | 0.15 |
Large LDL- mass |
0.21 | −0.13 | −0.21 | 0.14 | 0.05 | −0.03 | 0.04 | −0.16 | −0.21 |
IDL-mass | 0.51**** | 0.14 | −0.03 | 0.50** | 0.27 | 0.02 | 0.47*** | 0.25 | 0.00 |
VLDL-mass | 0.43**** | 0.16 | 0.02 | 0.23 | 0.29 | 0.21 | 0.11 | 0.22 | 0.20 |
LDL peak Sf rate |
−0.39*** | −0.27* | −0.16 | −0.34 | −0.17 | 0.01 | −0.41** | −0.33* | −0.15 |
Apo A-I | 0.17 | 0.14 | 0.09 | −0.10 | 0.12 | 0.19 | 0.26 | 0.14 | 0.00 |
Apo A-II | 0.15 | 0.21 | 0.17 | 0.49** | 0.33 | 0.10 | 0.08 | 0.09 | 0.05 |
Apo B | 0.70**** | 0.37*** | 0.21 | 0.76**** | 0.50** | 0.21 | 0.50*** | 0.35* | 0.12 |
BMI | 0.21 | 0.24* | 0.19 | 0.52** | 0.31 | 0.06 | 0.16 | 0.14 | 0.07 |
Significance levels for Pearson correlations are coded:
P < 0.05;
P < 0.01;
P < 0.001;
P < 0.00001.